Intravenous Palivizumab and Ribavirin Combination for Respiratory Syncytial Virus Disease in High-Risk Pediatric Patients

Journal article

Peer reviewed

Susana CHDVEZ-BUENO, Asuncion Mejias, Ruth A Merryman, Naveed Ahmad, Hasan S Jafri and Octavio Ramilo

The Pediatric infectious disease journal, Vol.26(12), pp.1089-1093

12/2007

PMID: 18043443

Abstract

Biological and medical sciences

Human viral diseases

Immunodeficiencies

Immunodeficiencies. Immunoglobulinopathies

Immunomodulators

Immunopathology

Infectious diseases

Medical sciences

Pharmacology. Drug treatments

Viral diseases

Viral diseases of the respiratory system and ent viral diseases

1 Record Views

Title: Intravenous Palivizumab and Ribavirin Combination for Respiratory Syncytial Virus Disease in High-Risk Pediatric Patients
Creators - without role: Susana CHDVEZ-BUENO - The University of Texas Southwestern Medical Center
Asuncion Mejias - The University of Texas Southwestern Medical Center
Ruth A Merryman - Children's Medical Center
Naveed Ahmad - Pediatrics and Genetics
Hasan S Jafri - The University of Texas Southwestern Medical Center
Octavio Ramilo - The University of Texas Southwestern Medical Center
Publication Details: The Pediatric infectious disease journal, Vol.26(12), pp.1089-1093
Publisher: Lippincott
Identifiers: 9921591008331
Academic Unit: King Abdulaziz University; King Saud Bin Abdulaziz University for Health Sciences
Language: English
Resource Type: Journal article